insights_auto
Why is BEAM up 16.16%?
Dive Deeperchevron_right
BEAM:BMV
Beam Therapeutics Inc
MX$492.00
arrow_upward
+16.16%(+68.45) 1D
Nov 10, 10:08:16 AM GMT-6 · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BEAM...
Mkt. cap
2.17B
Avg. vol.
6.00
Volume
0.00
52-wk high
MX$663.44
52-wk low
MX$384.79
No. of employees
557
Mkt. cap
2.17B
Avg. vol.
6.00
Volume
0.00
52-wk high
MX$663.44
52-wk low
MX$384.79
No. of employees
557
News stories
From web sources and news partners
Yahoo Finance
·
4 hours ago
Positive Trial Results Could Be A Big Moment For Beam Therapeutics (BEAM)
Investing.com
·
14 hours ago
Beam Therapeutics at Jefferies: base editing moves toward market
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc
CEOJohn Evans
Employees557
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitebeamtx.com